Clearside jumps after reporting results from Cohort 1 of its OASIS trial Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Clearside (CLSD) up 37% after achieving primary endpoints in Cohort 1 of its OASIS trial
- Unique Fabricating (UFAB) up 30% after extending its forbearance agreement with its lenders through February 28, 2022
- Blucora (BCOR) up 1% after raising Q2 and FY21 guidance following better-than-anticipated tax season results
- Spirit Airlines (SAVE) up 3.5% after reporting it has seen an improvement in operating yields and now expects its EBITDA margin, excluding special items, for Q2 to be modestly positive
DOWN AFTER EARNINGS -
LOWER -
- Decarbonization Plus Acquisition III (DCRC) down 7% after the company and Solid Power announced a definitive agreement for a business combination that would result in Solid Power becoming a publicly listed company
- Document Security (DSS) down 42% after 29M share Spot Secondary priced at $1.50
- Sage Therapeutics (SAGE) down 11% after the company and Biogen (BIIB) announced that the WATERFALL Study in patients with MDD met its primary endpoint and that the rate of treatment emergent adverse events in the zuranolone group was 60.1% compared to the placebo group at 44.6%
- Ping Identity (PING) down 5% after 6M share Spot Secondary in the price range of $24.00-$24.25
- Novavax (NVAX) down 3% after reporting findings that suggest simultaneous flu and COVID-19 vaccination may be a viable immunization strategy
Symbols:
BCOR CLSD SAVE NVAX QD DCRCDecarbonization Plus Acquisition III
DSS SAGE PING UFAB Keywords: movers, pre-market